Observational studyBritish journal of sports medicine2019
Common cold in Team Finland during 2018 Winter Olympic Games (PyeongChang): epidemiology, diagnosis including molecular point-of-care testing (POCT) and treatment.
Observational study in British journal of sports medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 55 citations in OpenAlex.
- ColdZyme® reduces viral load and upper respiratory tract infection duration and protects airway epithelia from infection with human rhinoviruses.The Journal of physiology · 2025Trial
- Influence of Vitamin D Supplementation by Simulated Sunlight or Oral D3 on Respiratory Infection during Military Training.Medicine and science in sports and exercise · 2021Trial
- Respiratory viral infections in professional ice hockey teams-a one-season observational study.Frontiers in sports and active living · 2026Article
- Antioxidants and Exercise Performance: Focus on Mediterranean Diet.Antioxidants (Basel, Switzerland) · 2025Review
- Preparing for Potential Health and Safety Risks at the Olympic Games: Scoping Review.JMIR public health and surveillance · 2025Article
- Vaccinations for Elite Athletes.Vaccines · 2025Article
- Rigorous methodological approaches to address knowledge gaps in exercise, nutrition, immunity, and infection risk research.Physiological reports · 2025Review
- Viral acute respiratory illnesses in elite athletes: A 12-month controlled follow-up study.PloS one · 2025Article
- An Outbreak of Respiratory Viral Infections in a Professional Ice Hockey Team.Influenza and other respiratory viruses · 2024Article
- Sport and exercise during viral acute respiratory illness-Time to revisit.Journal of sport and health science · 2024Article
- Development and implementation of an injury and illness surveillance system for team USA.Injury epidemiology · 2024Article
- Contraction of Respiratory Viral Infection During air Travel: An Under-Recognized Health Risk for Athletes.Sports medicine - open · 2024Article
- Methylene-Blue-Encapsulated Metal-Organic-Framework-Based Electrochemical POCT Platform for Multiple Detection of Heavy Metal Ions in Milk.Biosensors · 2023Article
- Cardiac changes in collegiate athletes following SARS-CoV-2 infection and quarantine: a prospective Case-Control study.Annals of medicine · 2023Article
- Article
- Risks, Epidemics, and Prevention Measures of Infectious Diseases in Major Sports Events: Scoping Review.JMIR public health and surveillance · 2022Article
- Non-SARS-CoV-2 Respiratory Viruses in Athletes at Major Winter Sport Events, 2021 and 2022.Emerging infectious diseases · 2022Article
- Respiratory Viral Infections in Athletes: Many Unanswered Questions.Sports medicine (Auckland, N.Z.) · 2022Article
- A new dynamic deep learning noise elimination method for chip-based real-time PCR.Analytical and bioanalytical chemistry · 2022Article
- Survey of Viral Reactivations in Elite Athletes: A Case-Control Study.Pathogens (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe common cold is the main cause of medical time loss in elite sport. Rapid diagnosis has been a challenge that may be amenable to molecular point-of-care testing (POCT).
methodsWe performed a prospective observational study of the common cold in Team Finland during the 2018 Winter Olympic Games. There were 44 elite athletes and 68 staff members. The chief physician recorded the symptoms of the common cold daily on a standardised form. Two nasal swabs were taken at the onset of symptoms. One swab was analysed within 45 min using a molecular POCT for respiratory syncytial virus and influenza A and B viruses. After the Games, the other swab was tested for 16 possible causative respiratory viruses using PCR in laboratory-based testing.
results20 out of 44 (45%) athletes and 22 out of 68 (32%) staff members experienced symptoms of the common cold during a median stay of 21 days. Eleven (26%) samples tested virus-positive using POCT. All subjects with influenza (n=6) and 32 close contacts were treated with oseltamivir. The aetiology of the common cold was finally detected in 75% of the athletes and 68 % of the staff members. Seven virus clusters were identified. They were caused by coronaviruses 229E, NL63 and OC43, influenza B virus, respiratory syncytial virus A, rhinovirus and human metapneumovirus. The virus infections spread readily within the team, most commonly within the same sport discipline.
conclusionsThe cold was indeed a common illness in Team Finland during the Winter Olympic Games. POCT proved to be clinically valuable, especially for influenza. The aetiology of the common cold was identified in most cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.